SLIT2 inhibits cell migration in colorectal cancer through the AKT-GSK3β signaling pathway

Related Experiment Video

Updated: May 15, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Wei-Feng Chen1, Wei-Dong Gao, Quan-Lin Li

  • 1Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, 180 FengLin Road, 200032, Shanghai, People's Republic of China.

International Journal of Colorectal Disease
|January 15, 2013
PubMed
Abstract

Insights

SLIT2 inhibits colon tumor metastasis by suppressing AKT signaling and epithelial-mesenchymal transition (EMT). This finding highlights SLIT2 as a potential prognostic marker for colorectal cancer patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer mortality globally.
  • Tumor metastasis remains a significant challenge in CRC treatment.
  • Understanding the molecular mechanisms of metastasis is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the functional role of SLIT2 in colon tumor metastasis.
  • To elucidate the molecular mechanisms underlying SLIT2's effect on metastasis.
  • To evaluate SLIT2 as a potential prognostic marker for colorectal cancer.

Main Methods:

  • Immunohistochemistry and molecular assays to assess SLIT2 expression in tumor tissues.
  • Cell migration assays (wound-healing, Transwell) to evaluate SLIT2's impact on cell movement.
  • Western blotting, immunofluorescence, and AKT inhibition to explore signaling pathways and epithelial-mesenchymal transition (EMT).

Main Results:

  • Higher SLIT2 expression correlated with reduced metastasis and improved patient survival.
  • SLIT2 inhibited SW480 cell migration and SLIT2 depletion enhanced NCM460 cell migration.
  • SLIT2 depletion induced EMT and β-catenin accumulation, effects abrogated by AKT inhibition.

Conclusions:

  • SLIT2 suppresses colon tumor metastasis by inhibiting AKT signaling and EMT.
  • SLIT2 demonstrates potential as a clinical prognostic marker for colorectal cancer.
  • Targeting SLIT2 or its pathways may offer therapeutic strategies for metastatic CRC.

More Related Videos

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cytoskeletal Coordination in Cell Migration01:32

Cytoskeletal Coordination in Cell Migration

A migrating cell changes its shape during the cyclic events of attachment and detachment from the substratum and repositions the cell organelles correspondingly. These complex events are orchestrated by the dynamic cytoskeletal network comprising actin filaments, intermediate filaments, and microtubules. Cytoskeletal crosstalk — the direct and indirect communication between the different components — is crucial for this coordination. Direct communication involves various linker proteins that...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...